Jill Feldman
@jillfeldman4.bsky.social
Lung Cancer Patient and Advocate, Co-Founder @EGFRResisters, #LCSM #LungCancer #EndStigma #EndJewHate
Deadline is approaching!
Are you doing research in #EGFR+ #lungcancer — OR mentoring someone who is — submit an abstract to the EGFR Resisters Research Summit
Concepts welcome
Deadline-August 8.
Submit Abstract - ceconcepts.com/egfr-summit
#NSCLC #ThoracicOnc #HOFellows #EGFRResisters
#OncoAlert
Are you doing research in #EGFR+ #lungcancer — OR mentoring someone who is — submit an abstract to the EGFR Resisters Research Summit
Concepts welcome
Deadline-August 8.
Submit Abstract - ceconcepts.com/egfr-summit
#NSCLC #ThoracicOnc #HOFellows #EGFRResisters
#OncoAlert
July 29, 2025 at 1:02 PM
Deadline is approaching!
Are you doing research in #EGFR+ #lungcancer — OR mentoring someone who is — submit an abstract to the EGFR Resisters Research Summit
Concepts welcome
Deadline-August 8.
Submit Abstract - ceconcepts.com/egfr-summit
#NSCLC #ThoracicOnc #HOFellows #EGFRResisters
#OncoAlert
Are you doing research in #EGFR+ #lungcancer — OR mentoring someone who is — submit an abstract to the EGFR Resisters Research Summit
Concepts welcome
Deadline-August 8.
Submit Abstract - ceconcepts.com/egfr-summit
#NSCLC #ThoracicOnc #HOFellows #EGFRResisters
#OncoAlert
Reposted by Jill Feldman
Heading to #ASCO25 this year? Be sure to join us for the first ever #ASPIRE Community of Practice on Friday, May 30th: 4-6pm CST in E253cd. We have a great agenda and opportunity to connect with other #irAE aficionados @ascocancer.bsky.social @funchainmd.bsky.social www.asco.org/annual-meeti...
May 15, 2025 at 7:20 PM
Heading to #ASCO25 this year? Be sure to join us for the first ever #ASPIRE Community of Practice on Friday, May 30th: 4-6pm CST in E253cd. We have a great agenda and opportunity to connect with other #irAE aficionados @ascocancer.bsky.social @funchainmd.bsky.social www.asco.org/annual-meeti...
Reposted by Jill Feldman
Sick and tired of being sick and tired? Thanks @funchainmd.bsky.social & Afreen Shariff for the chance to discuss cancer-related fatigue @ascocancer.bsky.social @americancancersoc.bsky.social @pallonccop.bsky.social @oncoalert.bsky.social @aspire-cop.bsky.social podcasts.apple.com/us/podcast/e...
Episode 30: Fatigue and Cancer- Symptom of cancer or a sign of a toxicity?
Podcast Episode · Checkpoint NOW · 05/09/2025 · 42m
podcasts.apple.com
May 13, 2025 at 2:12 AM
Sick and tired of being sick and tired? Thanks @funchainmd.bsky.social & Afreen Shariff for the chance to discuss cancer-related fatigue @ascocancer.bsky.social @americancancersoc.bsky.social @pallonccop.bsky.social @oncoalert.bsky.social @aspire-cop.bsky.social podcasts.apple.com/us/podcast/e...
Reposted by Jill Feldman
Welcome #pallonc #supponc folks to the official Blue Sky account for ASCO supported #PallOncCoP. Please follow for official Zoom meeting events, in-person conference meet ups like pic #ASCO24 and sharing the latest science in comfort and cure.
November 23, 2024 at 10:05 AM
Welcome #pallonc #supponc folks to the official Blue Sky account for ASCO supported #PallOncCoP. Please follow for official Zoom meeting events, in-person conference meet ups like pic #ASCO24 and sharing the latest science in comfort and cure.
Reposted by Jill Feldman
I will co-chair with Prof Maryam Lustberg on June 26th AM
"Workshop 1: Partnering with patients in managing chronic toxicities of cancer and its treatment."
bringing together multidisciplinary professionals, cancer patients, survivors and carers to compare best practices for management toxicities.
"Workshop 1: Partnering with patients in managing chronic toxicities of cancer and its treatment."
bringing together multidisciplinary professionals, cancer patients, survivors and carers to compare best practices for management toxicities.
March 18, 2025 at 7:36 PM
I will co-chair with Prof Maryam Lustberg on June 26th AM
"Workshop 1: Partnering with patients in managing chronic toxicities of cancer and its treatment."
bringing together multidisciplinary professionals, cancer patients, survivors and carers to compare best practices for management toxicities.
"Workshop 1: Partnering with patients in managing chronic toxicities of cancer and its treatment."
bringing together multidisciplinary professionals, cancer patients, survivors and carers to compare best practices for management toxicities.
My Guiding Compass in Advocacy:
Speak up, but do it with respect.
Challenge, but do it with understanding.
And always push forward with purpose — Real change happens through conversation, not confrontation.
I was 28 when my mom died, but her profound wisdom always guides me 💙
Speak up, but do it with respect.
Challenge, but do it with understanding.
And always push forward with purpose — Real change happens through conversation, not confrontation.
I was 28 when my mom died, but her profound wisdom always guides me 💙
February 19, 2025 at 1:42 AM
My Guiding Compass in Advocacy:
Speak up, but do it with respect.
Challenge, but do it with understanding.
And always push forward with purpose — Real change happens through conversation, not confrontation.
I was 28 when my mom died, but her profound wisdom always guides me 💙
Speak up, but do it with respect.
Challenge, but do it with understanding.
And always push forward with purpose — Real change happens through conversation, not confrontation.
I was 28 when my mom died, but her profound wisdom always guides me 💙
Reposted by Jill Feldman
Jill Feldman wrote a powerful article for @curetoday.bsky.social about the #LungCancerGeneticsStudy – a collaboration between nearly two dozen #LungCancer organizations and 23andme to uncover the genetic risks of lung cancer. Read it at: www.curetoday.com/view/the-pow...
@jillfeldman4.bsky.social
@jillfeldman4.bsky.social
The Power of Unity: Why the Lung Cancer Genetics Study Matters
The Lung Cancer Genetics Study, a collaboration between lung cancer advocacy organizations, aims to explore the genetics of lung cancer
www.curetoday.com
January 23, 2025 at 9:38 PM
Jill Feldman wrote a powerful article for @curetoday.bsky.social about the #LungCancerGeneticsStudy – a collaboration between nearly two dozen #LungCancer organizations and 23andme to uncover the genetic risks of lung cancer. Read it at: www.curetoday.com/view/the-pow...
@jillfeldman4.bsky.social
@jillfeldman4.bsky.social
Reposted by Jill Feldman
ASCO has a palliative care community of practice in which a patient advocate pillar was organized with @jillfeldman4.bsky.social, Ameish, and I as members. I have served since September 2023 as the lead and will hand over the role later this year.
January 24, 2025 at 3:14 PM
ASCO has a palliative care community of practice in which a patient advocate pillar was organized with @jillfeldman4.bsky.social, Ameish, and I as members. I have served since September 2023 as the lead and will hand over the role later this year.
Reposted by Jill Feldman
Please email pallonccop@gmail.com to be added to the listserv.
January 24, 2025 at 7:39 PM
Please email pallonccop@gmail.com to be added to the listserv.
Words Matter isn't just a catchphrase. It is a simple yet profound truth when talking about #lungcancer
Thank you, Drs Jamie Ostroff & Smita Banerjee, for your efforts to develop a training that offers strategies for empathic communication to ⬇️ stigma bit.ly/4gWH1Si
#LCSM #EndStigmaNow
Thank you, Drs Jamie Ostroff & Smita Banerjee, for your efforts to develop a training that offers strategies for empathic communication to ⬇️ stigma bit.ly/4gWH1Si
#LCSM #EndStigmaNow
Helping Health Professionals Reduce Lung Cancer Stigma
Researchers have developed a training program to help health providers reduce lung cancer stigma and have launched a clinical trial to test the training.
bit.ly
January 16, 2025 at 5:42 PM
Words Matter isn't just a catchphrase. It is a simple yet profound truth when talking about #lungcancer
Thank you, Drs Jamie Ostroff & Smita Banerjee, for your efforts to develop a training that offers strategies for empathic communication to ⬇️ stigma bit.ly/4gWH1Si
#LCSM #EndStigmaNow
Thank you, Drs Jamie Ostroff & Smita Banerjee, for your efforts to develop a training that offers strategies for empathic communication to ⬇️ stigma bit.ly/4gWH1Si
#LCSM #EndStigmaNow
THIS!
Easy-to-use, available regimen significantly ⬇️ frequency & severity of Grade 2+ AEs SOC for patients on first-line Ami/Lazer.
Like “Stay ahead of the pain,” “Stay ahead of the side effects” boosts QOL & ⬇️ dose interrupt/discontine—a win for everyone. 👏
#LCSM #SuppOnc
bit.ly/4jiKwUz
Easy-to-use, available regimen significantly ⬇️ frequency & severity of Grade 2+ AEs SOC for patients on first-line Ami/Lazer.
Like “Stay ahead of the pain,” “Stay ahead of the side effects” boosts QOL & ⬇️ dose interrupt/discontine—a win for everyone. 👏
#LCSM #SuppOnc
bit.ly/4jiKwUz
COCOON study meets primary endpoint demonstrating statistically significant and clinically meaningful reduction in dermatologic reactions with easy-to-use prophylactic regimen for patients with EGFR-m...
bit.ly
January 14, 2025 at 3:04 PM
THIS!
Easy-to-use, available regimen significantly ⬇️ frequency & severity of Grade 2+ AEs SOC for patients on first-line Ami/Lazer.
Like “Stay ahead of the pain,” “Stay ahead of the side effects” boosts QOL & ⬇️ dose interrupt/discontine—a win for everyone. 👏
#LCSM #SuppOnc
bit.ly/4jiKwUz
Easy-to-use, available regimen significantly ⬇️ frequency & severity of Grade 2+ AEs SOC for patients on first-line Ami/Lazer.
Like “Stay ahead of the pain,” “Stay ahead of the side effects” boosts QOL & ⬇️ dose interrupt/discontine—a win for everyone. 👏
#LCSM #SuppOnc
bit.ly/4jiKwUz
What a pleasure it was to meet Donghoon Shin! His passion and desire to learn from patient advocates was genuine and impressive. The future of #lungcancer research is bright😎
#LCSM #EGFR
#LCSM #EGFR
Congrats Donghoon Shin on receiving an honorable mention at the @EGFRSummit Your research and passion for the field are truly impressive #ProudMentor
Huge shoutout to @EGFRResisters for giving trainees a platform to showcase their work! #LCSM 🙌🏼 @jillfeldman4.bsky.social
Huge shoutout to @EGFRResisters for giving trainees a platform to showcase their work! #LCSM 🙌🏼 @jillfeldman4.bsky.social
December 24, 2024 at 1:03 PM
What a pleasure it was to meet Donghoon Shin! His passion and desire to learn from patient advocates was genuine and impressive. The future of #lungcancer research is bright😎
#LCSM #EGFR
#LCSM #EGFR
Reposted by Jill Feldman
Innovation shouldn't come at the expense of patient-centered care!
Great article about prioritizing what matters to patients (QOL/OS/⬇️ burdens). It underscores palliative care being viewed as essential, not ancillary.
We must rethink how we define progress in #oncology
#pallonc #LCSM
bit.ly/3OJQuQB
Great article about prioritizing what matters to patients (QOL/OS/⬇️ burdens). It underscores palliative care being viewed as essential, not ancillary.
We must rethink how we define progress in #oncology
#pallonc #LCSM
bit.ly/3OJQuQB
The trade-off between accelerated cancer drug approvals and patient preferences
Cancer care stands at a critical juncture where the urgency of rapid drug approvals
must be balanced against the need for enduring patient-centric benefits. Robin Forrest
and colleagues1 conducted a d...
bit.ly
December 16, 2024 at 5:03 PM
Reposted by Jill Feldman
“The most common cause of death from cancer is from lung cancer…yet just 16% of eligible people get screened for lung cancer, far lower than screening rates for colorectal or breast cancer. “ #medsky ktul.com/news/nation-...
More people surviving lung cancer, but work remains in screening and biomarker testing
The American Lung Association has released its annual "State of Lung Cancer" report.
ktul.com
November 25, 2024 at 4:44 PM
“The most common cause of death from cancer is from lung cancer…yet just 16% of eligible people get screened for lung cancer, far lower than screening rates for colorectal or breast cancer. “ #medsky ktul.com/news/nation-...
Innovation shouldn't come at the expense of patient-centered care!
Great article about prioritizing what matters to patients (QOL/OS/⬇️ burdens). It underscores palliative care being viewed as essential, not ancillary.
We must rethink how we define progress in #oncology
#pallonc #LCSM
bit.ly/3OJQuQB
Great article about prioritizing what matters to patients (QOL/OS/⬇️ burdens). It underscores palliative care being viewed as essential, not ancillary.
We must rethink how we define progress in #oncology
#pallonc #LCSM
bit.ly/3OJQuQB
The trade-off between accelerated cancer drug approvals and patient preferences
Cancer care stands at a critical juncture where the urgency of rapid drug approvals
must be balanced against the need for enduring patient-centric benefits. Robin Forrest
and colleagues1 conducted a d...
bit.ly
November 25, 2024 at 1:38 PM
Innovation shouldn't come at the expense of patient-centered care!
Great article about prioritizing what matters to patients (QOL/OS/⬇️ burdens). It underscores palliative care being viewed as essential, not ancillary.
We must rethink how we define progress in #oncology
#pallonc #LCSM
bit.ly/3OJQuQB
Great article about prioritizing what matters to patients (QOL/OS/⬇️ burdens). It underscores palliative care being viewed as essential, not ancillary.
We must rethink how we define progress in #oncology
#pallonc #LCSM
bit.ly/3OJQuQB
Reposted by Jill Feldman
Only this week a patient asked me if thought she was foolish for declining further treatment. She is not foolish, it is the right decision for her.
It was an honor to co-author this article
bit.ly/40WN9Vr
It emphasizes the profound impact of a #lungcancer dx, highlighting the multifaceted challenges patients/families face.
It's time to transform the “one-way ticket” into an experience of hope, support & compassionate care.
#LCAM #LCSM
bit.ly/40WN9Vr
It emphasizes the profound impact of a #lungcancer dx, highlighting the multifaceted challenges patients/families face.
It's time to transform the “one-way ticket” into an experience of hope, support & compassionate care.
#LCAM #LCSM
Lung cancer—a one-way ticket
The physician’s duty is not to stave off death or return patients to their old lives, but to take into our arms a patient and family whose lives have disin
bit.ly
November 21, 2024 at 1:59 PM
Only this week a patient asked me if thought she was foolish for declining further treatment. She is not foolish, it is the right decision for her.
It was an honor to co-author this article
bit.ly/40WN9Vr
It emphasizes the profound impact of a #lungcancer dx, highlighting the multifaceted challenges patients/families face.
It's time to transform the “one-way ticket” into an experience of hope, support & compassionate care.
#LCAM #LCSM
bit.ly/40WN9Vr
It emphasizes the profound impact of a #lungcancer dx, highlighting the multifaceted challenges patients/families face.
It's time to transform the “one-way ticket” into an experience of hope, support & compassionate care.
#LCAM #LCSM
Lung cancer—a one-way ticket
The physician’s duty is not to stave off death or return patients to their old lives, but to take into our arms a patient and family whose lives have disin
bit.ly
November 21, 2024 at 3:45 AM
It was an honor to co-author this article
bit.ly/40WN9Vr
It emphasizes the profound impact of a #lungcancer dx, highlighting the multifaceted challenges patients/families face.
It's time to transform the “one-way ticket” into an experience of hope, support & compassionate care.
#LCAM #LCSM
bit.ly/40WN9Vr
It emphasizes the profound impact of a #lungcancer dx, highlighting the multifaceted challenges patients/families face.
It's time to transform the “one-way ticket” into an experience of hope, support & compassionate care.
#LCAM #LCSM
Working on the #ASCO #SCLC guidelines, published in 2023, was disheartening, but working on the rapid update (based on #ASCO24 data) left me emotional.
This update represents hope & progress for patients who have waited far too long. ascopubs.org/doi/10.1200/...
#LCSM
This update represents hope & progress for patients who have waited far too long. ascopubs.org/doi/10.1200/...
#LCSM
Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update | Journal of Clinical Oncology
ASCO Rapid Recommendation Updates highlight revisions to select ASCO guideline recommendations
as a response to the emergence of new and practice-changing data. The rapid updates
are supported by an e...
ascopubs.org
November 21, 2024 at 1:53 AM
Working on the #ASCO #SCLC guidelines, published in 2023, was disheartening, but working on the rapid update (based on #ASCO24 data) left me emotional.
This update represents hope & progress for patients who have waited far too long. ascopubs.org/doi/10.1200/...
#LCSM
This update represents hope & progress for patients who have waited far too long. ascopubs.org/doi/10.1200/...
#LCSM
Reposted by Jill Feldman
Today's the day! Our last PallOncCoP meeting of 2024! Don't miss it. Not too late to DM📨 for Zoom 🔗. Always stay in the know by sending your prof email to pallonccop@gmail.com to be added to our listserv.
@darcyburbage.bsky.social
@tingtingzhang.bsky.social
@jillfeldman4.bsky.social
@darcyburbage.bsky.social
@tingtingzhang.bsky.social
@jillfeldman4.bsky.social
Looking forward to sharing our experience next week!
Join our #PallOncCoP next Wednesday for an interdisciplinary conversation on mentorship feat @ericroeland.bsky.social and @sarahlowry.bsky.social. DM for details or email pallonccop@gmail.com to be added to the listserv.
hapc hpm #pallonc #supponc CanSky MedSky
hapc hpm #pallonc #supponc CanSky MedSky
November 20, 2024 at 12:11 PM
Today's the day! Our last PallOncCoP meeting of 2024! Don't miss it. Not too late to DM📨 for Zoom 🔗. Always stay in the know by sending your prof email to pallonccop@gmail.com to be added to our listserv.
@darcyburbage.bsky.social
@tingtingzhang.bsky.social
@jillfeldman4.bsky.social
@darcyburbage.bsky.social
@tingtingzhang.bsky.social
@jillfeldman4.bsky.social
The #lungcancer screening team at RushCancer Center
has had a 50% uptake in screening for the 3rd year! Congratulations to Annie and the team, and thank you for your tireless efforts to raise awareness about lung cancer screening!
#LCSM #LCAM #EarlyDetectionSavesLives
has had a 50% uptake in screening for the 3rd year! Congratulations to Annie and the team, and thank you for your tireless efforts to raise awareness about lung cancer screening!
#LCSM #LCAM #EarlyDetectionSavesLives
November 15, 2024 at 12:35 PM
The #lungcancer screening team at RushCancer Center
has had a 50% uptake in screening for the 3rd year! Congratulations to Annie and the team, and thank you for your tireless efforts to raise awareness about lung cancer screening!
#LCSM #LCAM #EarlyDetectionSavesLives
has had a 50% uptake in screening for the 3rd year! Congratulations to Annie and the team, and thank you for your tireless efforts to raise awareness about lung cancer screening!
#LCSM #LCAM #EarlyDetectionSavesLives
Great episode Dr Ross Camidge's podcast #HowThisIsBuildingMe with pharmacologist Dr. Zirkelbach (FDA Onc) on drug dev & her focus on #PROs for best outcomes w/fewest AEs
I always learn, but still have questions about #ProjectOptimus
bit.ly/48RlOpz
#LCAM #LCSM #TheRightDose
@itsnotpink.bsky.social
I always learn, but still have questions about #ProjectOptimus
bit.ly/48RlOpz
#LCAM #LCSM #TheRightDose
@itsnotpink.bsky.social
FDA Involvement in Dose Optimization Through Project Optimus Drives a Patient-Focused Oncology Pharmacology Career: With D. Ross Camidge, MD, PhD; and Jeanne Fourie Zirkelbach, PhD
Drs Camidge and Zirkelbach discuss Zirkelbach's first pharmacokinetics forays and her involvement with reforming dose optimization in drug development.
bit.ly
November 14, 2024 at 1:38 PM
Great episode Dr Ross Camidge's podcast #HowThisIsBuildingMe with pharmacologist Dr. Zirkelbach (FDA Onc) on drug dev & her focus on #PROs for best outcomes w/fewest AEs
I always learn, but still have questions about #ProjectOptimus
bit.ly/48RlOpz
#LCAM #LCSM #TheRightDose
@itsnotpink.bsky.social
I always learn, but still have questions about #ProjectOptimus
bit.ly/48RlOpz
#LCAM #LCSM #TheRightDose
@itsnotpink.bsky.social
📢 The @ASCO released updated living guidelines for treating stage IV #NSCLC with driver alterations! ascopubs.org/doi/10.1200/....
This is no easy feat, but it was an honor to work alongside exceptional experts dedicated to providing the most up-to-date, evidence-based guidance.
#LCSM #LCAM
This is no easy feat, but it was an honor to work alongside exceptional experts dedicated to providing the most up-to-date, evidence-based guidance.
#LCSM #LCAM
November 13, 2024 at 2:04 PM
📢 The @ASCO released updated living guidelines for treating stage IV #NSCLC with driver alterations! ascopubs.org/doi/10.1200/....
This is no easy feat, but it was an honor to work alongside exceptional experts dedicated to providing the most up-to-date, evidence-based guidance.
#LCSM #LCAM
This is no easy feat, but it was an honor to work alongside exceptional experts dedicated to providing the most up-to-date, evidence-based guidance.
#LCSM #LCAM
Reposted by Jill Feldman
The "Living" #ASCOGuidelines embraces change and supports #OncSky clinicians and people LIVING with mutation-driven lung cancer in making informed treatment choices. Congrats to the expert panel! ascopubs.org/doi/full/10.... @jillfeldman4.bsky.social #LCSM
Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2 | Journal of Clinical Oncology
Living guidelines are developed for selected topic areas with rapidly evolving evidence
that drives frequent change in recommended clinical practice. Living guidelines are
updated on a regular schedul...
ascopubs.org
November 13, 2024 at 12:31 PM
The "Living" #ASCOGuidelines embraces change and supports #OncSky clinicians and people LIVING with mutation-driven lung cancer in making informed treatment choices. Congrats to the expert panel! ascopubs.org/doi/full/10.... @jillfeldman4.bsky.social #LCSM
Reposted by Jill Feldman
Voting in the ASCO Election is open now until December 3! Meet the candidates for the Board of Directors – Undesignated Member seat.
Learn more about each candidate, determine your voting eligibility, and make your voice heard at brnw.ch/21wOzu3
Learn more about each candidate, determine your voting eligibility, and make your voice heard at brnw.ch/21wOzu3
ASCO Election
ASCO Election
brnw.ch
November 12, 2024 at 3:48 PM
Voting in the ASCO Election is open now until December 3! Meet the candidates for the Board of Directors – Undesignated Member seat.
Learn more about each candidate, determine your voting eligibility, and make your voice heard at brnw.ch/21wOzu3
Learn more about each candidate, determine your voting eligibility, and make your voice heard at brnw.ch/21wOzu3
Reposted by Jill Feldman
"the new generation of cancer survivor [is] younger, less financially secure, and still having to navigate life after treatment, from dating to career, sex and child rearing"
So glad that #AYAcsm #survonc #financialToxicity & #MBC issues are getting time on NPR
www.npr.org/2024/11/11/n...
So glad that #AYAcsm #survonc #financialToxicity & #MBC issues are getting time on NPR
www.npr.org/2024/11/11/n...
November 12, 2024 at 3:50 AM
"the new generation of cancer survivor [is] younger, less financially secure, and still having to navigate life after treatment, from dating to career, sex and child rearing"
So glad that #AYAcsm #survonc #financialToxicity & #MBC issues are getting time on NPR
www.npr.org/2024/11/11/n...
So glad that #AYAcsm #survonc #financialToxicity & #MBC issues are getting time on NPR
www.npr.org/2024/11/11/n...